324 related articles for article (PubMed ID: 19447317)
1. Understanding the genetic determinants of pain and pain management.
Miaskowski C
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in pain management: the clinical need.
Webster LR
Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
[TBL] [Abstract][Full Text] [Related]
3. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
Adegbola MA
Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
[TBL] [Abstract][Full Text] [Related]
4. Current evidence for a genetic modulation of the response to analgesics.
Lötsch J; Geisslinger G
Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
[No Abstract] [Full Text] [Related]
5. Genetic factors in pain and its treatment.
Stamer UM; Stüber F
Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
[TBL] [Abstract][Full Text] [Related]
6. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
7. Understanding opioid tolerance in cancer pain.
Cady J
Oncol Nurs Forum; 2001; 28(10):1561-8; quiz 1569-70. PubMed ID: 11759304
[TBL] [Abstract][Full Text] [Related]
8. The use of risk-management approaches to protect patients with cancer-related pain and their healthcare providers.
Miaskowski C
Oncol Nurs Forum; 2008 Nov; 35 Suppl():20-4. PubMed ID: 18980936
[TBL] [Abstract][Full Text] [Related]
9. Clinical challenges: chemotherapy-induced peripheral neuropathy.
Paice JA
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in palliative care.
Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM
Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477
[TBL] [Abstract][Full Text] [Related]
11. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
12. [Individual differences in analgesic effects of narcotics].
Ide S; Kasai S; Ikeda K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
[TBL] [Abstract][Full Text] [Related]
13. Effect of genetic factors on opioid action.
Kosarac B; Fox AA; Collard CD
Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the pharmacogenomics of pain and headache.
Montagna P
Neurol Sci; 2007 May; 28 Suppl 2():S208-12. PubMed ID: 17508172
[TBL] [Abstract][Full Text] [Related]
15. The application of genomic and molecular data in the treatment of chronic cancer pain.
Turabi A; Plunkett AR
J Surg Oncol; 2012 Apr; 105(5):494-501. PubMed ID: 22441902
[TBL] [Abstract][Full Text] [Related]
16. Clinical approaches to special issues related to opioid therapy.
Fine PG
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S20-8. PubMed ID: 19447318
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphisms and opioid therapies].
Landau R
Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
[TBL] [Abstract][Full Text] [Related]
18. Cancer genetics nursing: impact of the double helix.
Greco KE
Oncol Nurs Forum; 2000 Oct; 27(9 Suppl):29-36. PubMed ID: 11058981
[TBL] [Abstract][Full Text] [Related]
19. [Pain and genetics].
Møller AT; Kølvraa S; Jensen TS
Ugeskr Laeger; 2006 May; 168(20):1944-7. PubMed ID: 16768888
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of opioid pharmacogenetics.
Argoff CE
Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
